Literature DB >> 10653084

Treatment of extrinsic flexion deformity of the toes associated with previous removal of a vascularized fibular graft.

Y Takakura1, H Yajima, Y Tanaka, T Komeda, S Tamai.   

Abstract

BACKGROUND: Complications from vascularized fibular bone-grafting are infrequent. We saw six patients who had a painful flexion deformity of the great and lesser toes after a free vascularized fibular graft had been obtained from the ipsilateral leg. In this report, we discuss our management of these patients.
METHODS: Painful flexion deformity of the toes that had developed in six adults after removal of a free vascularized fibular graft was treated by cutting of the flexor hallucis longus alone in three patients, by lengthening of the flexor hallucis longus alone in one, and by cutting of both the flexor hallucis longus and the flexor digitorum longus in two.
RESULTS: After an average duration of follow-up of six years and eleven months, the flexion deformity of the great and lesser toes had decreased or disappeared, leading to improved or full extension of the digits. Preoperative and postoperative measurements of muscle strength for plantar flexion of the interphalangeal joints did not change appreciably.
CONCLUSIONS: Cutting or lengthening of the flexor hallucis longus behind the ankle provides an adequate release of digital flexion deformities that occur after removal of a vascularized fibular bone graft.

Entities:  

Mesh:

Year:  2000        PMID: 10653084     DOI: 10.2106/00004623-200001000-00007

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  1 in total

1.  Indications for free vascularized fibular grafting for the treatment of osteonecrosis of the femoral head.

Authors:  Kenji Kawate; Hiroshi Yajima; Kazuya Sugimoto; Hiroshi Ono; Tetsuji Ohmura; Yasunori Kobata; Keiichi Murata; Koji Shigematsu; Kenji Kawamura; Ikuo Kawahara; Naoki Maegawa; Katsuya Tamai; Yoshinori Takakura; Susumu Tamai
Journal:  BMC Musculoskelet Disord       Date:  2007-08-08       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.